Arcutis Announces Inclusion of Children in On-going Pivotal Phase 3 Clinical Trials Evaluating Topical Roflumilast (ARQ-151) as a Potential Once Daily Topical Treatment for Plaque Psoriasis March 16, 2020 - NASDAQ Companies 0 Bay Street News » View More News for March 16, 2020